The changing landscape of the vaginal microbiome

Clinics in Laboratory Medicine

Volumn 34, Issue 4, 2014, Pages 747-761

  Huang, Bernice ^a   Fettweis, Jennifer M ^a   Brooks, J Paul ^a   Jefferson, Kimberly K ^a   Buck, Gregory A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Bacterial vaginosis; Metagenomics; Microbiota; Pregnancy; Preterm birth; Vaginal microbiome

Indexed keywords

RNA 16S;

ADVERSE OUTCOME; ANAEROBIC BACTERIUM; ANAEROCOCCUS; ATOPOBIUM; BACTERIAL OVERGROWTH; CORYNEBACTERIUM; CULTURAL FACTOR; ENVIRONMENTAL FACTOR; GARDNERELLA; HEREDITY; HUMAN; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS GASSERI; LACTOBACILLUS INERS; LACTOBACILLUS JENSENII; MICROBIOME; MICROENVIRONMENT; MOBILUNCUS; NONHUMAN; PEPTONIPHILUS; PREGNANCY OUTCOME; PREMATURE LABOR; PREVOTELLA; PRIORITY JOURNAL; REVIEW; RNA SEQUENCE; SEQUENCE ANALYSIS; STILLBIRTH; VAGINA FLORA; VAGINA PH; VAGINITIS; FEMALE; FEMALE UROGENITAL DISEASES; MICROBIOLOGY; MICROFLORA; PATHOLOGY; PHYSIOLOGY; PREGNANCY; PREMATURITY; VAGINA;

FEMALE; FEMALE UROGENITAL DISEASES; HUMANS; LACTOBACILLUS; MICROBIOTA; PREGNANCY; PREMATURE BIRTH; VAGINA; VAGINOSIS, BACTERIAL;

EID: 84923922201     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2014.08.006     Document Type: Review

References (94)

1. Cash H.L., Whitham C.V., Behrendt C.L., et al. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313(5790):1126-1130. 10.1126/science.1127119.
2. Doerflinger S.Y., Throop A.L., Herbst-Kralovetz M.M. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. JInfect Dis 2014, 10.1093/infdis/jiu004.
3. NIH HMP Working Group, Peterson J., Garges S., et al. The NIH Human Microbiome Project. Genome Res 2009, 19(12):2317-2323. 10.1101/gr.096651.109.
4. Ehrlich S. MetaHIT: the european union project on metagenomics of the human intestinal tract. Metagenomics of the human body 2011, 307-316. Springer, NewYork. 10.1007/978-1-4419-7089-3_15. K.E. Nelson (Ed.).
5. Arumugam M., Raes J., Pelletier E., et al. Enterotypes of the human gut microbiome. Nature 2011, 473(7346):174-180. 10.1038/nature09944.
6. Anderson L.S., Beverly W.T., Corey L.A., et al. The mid-atlantic twin registry. Twin Res 2002, 5(5):449-455. 10.1375/136905202320906264.
7. Kuczynski J., Lauber C.L., Walters W.A., et al. Experimental and analytical tools for studying the human microbiome. Nat Rev Genet 2012, 13(1):47-58. 10.1038/nrg3129.
8. Fettweis J.M., Serrano M.G., Sheth N.U., et al. Species-level classification of the vaginal microbiome. BMC Genomics 2012, 13(Suppl 8):S17. 10.1186/1471-2164-13-S8-S17.
9. Donders G.G., Bosmans E., Dekeersmaecker A., et al. Pathogenesis of abnormal vaginal bacterial flora. Am J Obstet Gynecol 2000, 182(4):872-878.
10. Aroutcheva A., Gariti D., Simon M., et al. Defense factors of vaginal lactobacilli. Am J Obstet Gynecol 2001, 185(2):375-379. 10.1067/mob.2001.115867.
11. Eschenbach D.A., Davick P.R., Williams B.L., et al. Prevalence of hydrogen peroxide-producing lactobacillus species in normal women and women with bacterial vaginosis. JClin Microbiol 1989, 27(2):251-256.
12. Ravel J., Gajer P., Abdo Z., et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 2011, 108(Suppl 1):4680-4687.
13. Yamamoto T., Zhou X., Williams C.J., et al. Bacterial populations in the vaginas of healthy adolescent women. JPediatr Adolesc Gynecol 2009, 22(1):11-18.
14. Fettweis J.M., Brooks J.P., Serrano M.G., et al. Differences in vaginal microbiome in african american women versus women of european ancestry. Microbiology 2014, 10.1099/mic.0.081034-0.
15. Pavlova S.I., Kilic A.O., Kilic S.S., et al. Genetic diversity of vaginal lactobacilli from women in different countries based on 16S rRNA gene sequences. JAppl Microbiol 2002, 92(3):451-459.
16. Zhou X., Bent S.J., Schneider M.G., et al. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 2004, 150(Pt 8):2565-2573.
17. Gajer P., Brotman R.M., Bai G., et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med 2012, 4(132):132ra52. 10.1126/scitranslmed.3003605.
18. Witkin S.S., Mendes-Soares H., Linhares I.M., et al. Influence of vaginal bacteria and d- and l-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections. MBio 2013, 4(4). 10.1128/mBio.00460-13.
19. O'Hanlon D.E., Moench T.R., Cone R.A. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One 2013, 8(11):e80074. 10.1371/journal.pone.0080074.
20. O'Hanlon D.E., Moench T.R., Cone R.A. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect Dis 2011, 11:200. 10.1186/1471-2334-11-200.
21. O'Hanlon D.E., Lanier B.R., Moench T.R., et al. Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli. BMC Infect Dis 2010, 10:120. 10.1186/1471-2334-10-120.
22. Selle K., Klaenhammer T.R. Genomic and phenotypic evidence for probiotic influences of lactobacillus gasseri on human health. FEMS Microbiol Rev 2013, 37(6):915-935. 10.1111/1574-6976.12021.
23. Zárate G., Nader-Macias M.E. Influence of probiotic vaginal lactobacilli on invitro adhesion of urogenital pathogens to vaginal epithelial cells. Lett Appl Microbiol 2006, 43(2):174-180. 10.1111/j.1472-765X.2006.01934.x.
24. Zárate G., Santos V., Nader-Macias M.E. Protective effect of vaginal lactobacillus paracasei cRL 1289 against urogenital infection produced by staphylococcus aureus in a mouse animal model. Infect Dis Obstet Gynecol 2009, 2009:48358. 10.1155/2007/48358.
25. Boris S., Suárez J.E., Vázquez F., et al. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun 1998, 66(5):1985-1989.
26. O'Sullivan O., O'Callaghan J., Sangrador-Vegas A., et al. Comparative genomics of lactic acid bacteria reveals a niche-specific gene set. BMC Microbiol 2009, 9:50. 10.1186/1471-2180-9-50.
27. Mendes-Soares H., Suzuki H., Hickey R.J., et al. Comparative functional genomics of lactobacillus spp. reveals possible mechanisms for specialization of vaginal lactobacilli to their environment. JBacteriol 2014, 10.1128/JB.01439-13.
28. Atassi F., Brassart D., Grob P., et al. Lactobacillus strains isolated from the vaginal microbiota of healthy women inhibit prevotella bivia and gardnerella vaginalis in coculture and cell culture. FEMS Immunol Med Microbiol 2006, 48(3):424-432. 10.1111/j.1574-695X.2006.00162.x.
29. Kaewsrichan J., Peeyananjarassri K., Kongprasertkit J. Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens. FEMS Immunol Med Microbiol 2006, 48(1):75-83. 10.1111/j.1574-695X.2006.00124.x.
30. Osset J., Bartolomé R.M., García E., et al. Assessment of the capacity of lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. JInfect Dis 2001, 183(3):485-491. 10.1086/318070.
31. Spurbeck R.R., Arvidson C.G. Inhibition of neisseria gonorrhoeae epithelial cell interactions by vaginal lactobacillus species. Infect Immun 2008, 76(7):3124-3130. 10.1128/IAI.00101-08.
32. Mastromarino P., Brigidi P., Macchia S., et al. Characterization and selection of vaginal lactobacillus strains for the preparation of vaginal tablets. JAppl Microbiol 2002, 93(5):884-893.
33. Reid G., McGroarty J.A., Angotti R., et al. Lactobacillus inhibitor production against escherichia coli and coaggregation ability with uropathogens. Can J Microbiol 1988, 34(3):344-351.
34. Hyman R.W., Fukushima M., Diamond L., et al. Microbes on the human vaginal epithelium. Proc Natl Acad Sci USA 2005, 102(22):7952-7957. 10.1073/pnas.0503236102.
35. Verhelst R., Verstraelen H., Claeys G., et al. Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol 2004, 4:16.
36. Harwich M.D., Serrano M.G., Fettweis J.M., et al. Genomic sequence analysis and characterization of sneathia amnii sp. nov. BMC Genomics 2012, 13(Suppl8):S4. 10.1186/1471-2164-13-S8-S4.
37. Shi Y., Chen L., Tong J., et al. Preliminary characterization of vaginal microbiota inhealthy chinese women using cultivation-independent methods. JObstet Gynaecol Res 2009, 35(3):525-532. 10.1111/j.1447-0756.2008.00971.x.
38. Witkin S.S., Ledger W.J. Complexities of the uniquely human vagina. Sci Transl Med 2012, 4(132):132fs11. 10.1126/scitranslmed.3003944.
39. Johnson S.R., Petzold C.R., Galask R.P. Qualitative and quantitative changes of thevaginal microbial flora during the menstrual cycle. Am J Reprod Immunol Microbiol 1985, 9(1):1-5.
40. Eschenbach D.A., Thwin S.S., Patton D.L., et al. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis 2000, 30(6):901-907.
41. Mitchell C.M., Fredricks D.N., Winer R.L., et al. Effect of sexual debut on vaginal microbiota in a cohort of young women. Obstet Gynecol 2012, 120(6):1306-1313. 10.1097/AOG.0b013e31827075ac.
42. Hooton T.M., Fennell C.L., Clark A.M., et al. Nonoxynol-9: differential antibacterial activity and enhancement of bacterial adherence to vaginal epithelial cells. JInfect Dis 1991, 164(6):1216-1219.
43. Hooton T.M., Hillier S., Johnson C., et al. Escherichia coli bacteriuria and contraceptive method. JAMA 1991, 265(1):64-69.
44. Aagaard K., Ma J., Antony K.M., et al. The placenta harbors a unique microbiome. Sci Transl Med 2014, 6(237):237ra65. 10.1126/scitranslmed.3008599.
45. Stout M.J., Conlon B., Landeau M., et al. Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations. Am J Obstet Gynecol 2013, 208(3):226.e1-226.e7. 10.1016/j.ajog.2013.01.018.
46. Romero R., Schaudinn C., Kusanovic J.P., et al. Detection of a microbial biofilm in intraamniotic infection. Am J Obstet Gynecol 2008, 198(1):135.e1-135.e5. 10.1016/j.ajog.2007.11.026.
47. Mändar R., Mikelsaar M. Transmission of mother's microflora to the newborn at birth. Biol Neonate 1996, 69(1):30-35.
48. Dominguez-Bello M.G., Costello E.K., Contreras M., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010, 107(26):11971-11975.
49. Jiménez E., Marín M.L., Martín R., et al. Is meconium from healthy newborns actually sterile?. Res Microbiol 2008, 159(3):187-193. 10.1016/j.resmic.2007.12.007.
50. Ardissone A.N., de la Cruz D.M., Davis-Richardson A.G., et al. Meconium microbiome analysis identifies bacteria correlated with premature birth. PLoS One 2014, 9(3):e90784. 10.1371/journal.pone.0090784.
51. Makino H., Kushiro A., Ishikawa E., et al. Transmission of intestinal bifidobacterium longum subsp. longum strains from mother to infant, determined by multilocus sequencing typing and amplified fragment length polymorphism. Appl Environ Microbiol 2011, 77(19):6788-6793. 10.1128/AEM.05346-11.
52. Makino H., Kushiro A., Ishikawa E., et al. Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant's microbiota. PLoS One 2013, 8(11):e78331. 10.1371/journal.pone.0078331.
53. Hammerschlag M.R., Alpert S., Rosner I., et al. Microbiology of the vagina in children: normal and potentially pathogenic organisms. Pediatrics 1978, 62(1):57-62.
54. Hammerschlag M.R., Alpert S., Onderdonk A.B., et al. Anaerobic microflora of the vagina in children. Am J Obstet Gynecol 1978, 131(8):853-856.
55. Jaquiery A., Stylianopoulos A., Hogg G., et al. Vulvovaginitis: clinical features, aetiology, and microbiology of the genital tract. Arch Dis Child 1999, 81(1):64-67.
56. Paavonen J. Physiology and ecology of the vagina. Scand J Infect Dis Suppl 1983, 40:31-35.
57. Zhou X., Brown C.J., Abdo Z., et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J 2007, 1(2):121-133.
58. Jennifer FA, Buck G. The vaginal microbiome: disease, genetics and the environment. 2011. Available at: . http://dxdoiorg/101038/npre201151502.
59. Gupta S., Kumar N., Singhal N., et al. Vaginal microflora in postmenopausal women on hormone replacement therapy. Indian J Pathol Microbiol 2006, 49(3):457-461.
60. Burton J.P., Reid G. Evaluation of the bacterial vaginal flora of 20 postmenopausal women by direct (Nugent score) and molecular (polymerase chain reaction and denaturing gradient gel electrophoresis) techniques. JInfect Dis 2002, 186(12):1770-1780.
61. Pabich W.L., Fihn S.D., Stamm W.E., et al. Prevalence and determinants of vaginal flora alterations in postmenopausal women. JInfect Dis 2003, 188(7):1054-1058. 10.1086/378203.
62. Genc M.R., Onderdonk A. Endogenous bacterial flora in pregnant women and the influence of maternal genetic variation. BJOG 2011, 118(2):154-163. 10.1111/j.1471-0528.2010.02772.x.
63. Verstraelen H., Verhelst R., Nuytinck L., et al. Gene polymorphisms of toll-like and related recognition receptors in relation to the vaginal carriage of gardnerella vaginalis and atopobium vaginae. JReprod Immunol 2009, 79(2):163-173. 10.1016/j.jri.2008.10.006.
64. Genc M.R., Schantz-Dunn J. The role of gene-environment interaction in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007, 21(3):491-504. 10.1016/j.bpobgyn.2007.01.009.
65. Jones N.M., Holzman C., Friderici K.H., et al. Interplay of cytokine polymorphisms and bacterial vaginosis in the etiology of preterm delivery. JReprod Immunol 2010, 87(1-2):82-89. 10.1016/j.jri.2010.06.158.
66. Morris M., Nicoll A., Simms I., et al. Bacterial vaginosis: a public health review. BJOG 2001, 108(5):439-450.
67. Srinivasan S., Fredricks D.N. The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis 2008, 2008:750479. 10.1155/2008/750479.
68. Leitich H., Bodner-Adler B., Brunbauer M., et al. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003, 189(1):139-147.
69. Hillier S.L., Krohn M.A., Cassen E., et al. The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. Clin Infect Dis 1995, 20(Suppl 2):S276-S278.
70. Sweet R.L. Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis 1995, 20(Suppl 2):S271-S275.
71. Schmid G., Markowitz L., Joesoef R., et al. Bacterial vaginosis and HIV infection. Sex Transm Infect 2000, 76(1):3-4.
72. Wiesenfeld H.C., Hillier S.L., Krohn M.A., et al. Bacterial vaginosis is a strong predictor of neisseria gonorrhoeae and chlamydia trachomatis infection. Clin Infect Dis 2003, 36(5):663-668. 10.1086/367658.
73. Bradshaw C.S., Morton A.N., Hocking J., et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. JInfect Dis 2006, 193(11):1478-1486. 10.1086/503780.
74. Fredricks D.N., Fiedler T.L., Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis. NEngl J Med 2005, 353(18):1899-1911.
75. Swidsinski A., Mendling W., Loening-Baucke V., et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol 2005, 106(5 Pt 1):1013-1023. 10.1097/01.AOG.0000183594.45524.d2.
76. Patterson J.L., Stull-Lane A., Girerd P.H., et al. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes. Microbiology 2010, 156(Pt 2):392-399. 10.1099/mic.0.034280-0.
77. Hedges S.R., Barrientes F., Desmond R.A., et al. Local and systemic cytokine levels in relation to changes in vaginal flora. JInfect Dis 2006, 193(4):556-562. 10.1086/499824.
78. Beigi R.H., Yudin M.H., Cosentino L., et al. Cytokines, pregnancy, and bacterial vaginosis: comparison of levels of cervical cytokines in pregnant and nonpregnant women with bacterial vaginosis. JInfect Dis 2007, 196(9):1355-1360. 10.1086/521628.
79. Amsel R., Totten P.A., Spiegel C.A., et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983, 74(1):14-22.
80. Nugent R.P., Krohn M.A., Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. JClin Microbiol 1991, 29(2):297-301.
81. Macklaim J.M., Fernandes A.D., Di Bella J.M., et al. Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome 2013, 1:12.
82. Zozaya-Hinchliffe M., Lillis R., Martin D.H., et al. Quantitative pCR assessments of bacterial species in women with and without bacterial vaginosis. JClin Microbiol 2010, 48(5):1812-1819. 10.1128/JCM.00851-09.
83. Randis T.M., Zaklama J., LaRocca T.J., et al. Vaginolysin drives epithelial ultrastructural responses to gardnerella vaginalis. Infect Immun 2013, 81(12):4544-4550. 10.1128/IAI.00627-13.
84. Macklaim J.M., Gloor G.B., Anukam K.C., et al. At the crossroads of vaginal health and disease, the genome sequence of lactobacillus iners aB-1. Proc Natl Acad Sci USA 2011, 108(Suppl 1):4688-4695. 10.1073/pnas.1000086107.
85. Menard J.-P., Fenollar F., Henry M., et al. Molecular quantification of gardnerella vaginalis and atopobium vaginae loads to predict bacterial vaginosis. Clin Infect Dis 2008, 47(1):33-43. 10.1086/588661.
86. Aagaard K., Riehle K., Ma J., et al. Ametagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS One 2012, 7(6):e36466. 10.1371/journal.pone.0036466.
87. Romero R., Hassan S.S., Gajer P., et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome 2014, 2(1):4. 10.1186/2049-2618-2-4.
88. Goldenberg R.L., Culhane J.F., Iams J.D., et al. Epidemiology and causes of preterm birth. Lancet 2008, 371(9606):75-84. 10.1016/S0140-6736(08)60074-4.
89. Iacovidou N., Varsami M., Syggellou A. Neonatal outcome of preterm delivery. Ann N Y Acad Sci 2010, 1205:130-134.
90. Goldenberg R.L., Hauth J.C., Andrews W.W. Intrauterine infection and preterm delivery. NEngl J Med 2000, 342(20):1500-1507. 10.1056/NEJM200005183422007.
91. Jefferson K.K. The bacterial etiology of preterm birth. Adv Appl Microbiol 2012, 80:1-22. 10.1016/B978-0-12-394381-1.00001-5.
92. Combs C.A., Gravett M., Garite T.J., et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol 2014, 210(2):125.e1-125.e15. 10.1016/j.ajog.2013.11.032.
93. Mercer B.M., Goldenberg R.L., Moawad A.H., et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National institute of child health and human development maternal-fetal medicine units network. Am J Obstet Gynecol 1999, 181(5 Pt 1):1216-1221.
94. Nelson D.B., Hanlon A., Nachamkin I., et al. Early pregnancy changes in bacterial vaginosis-associated bacteria and preterm delivery. Paediatr Perinat Epidemiol 2014, 10.1111/ppe.12106.